NCT04117347View on ClinicalTrials.gov

Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 24, 2020

Primary Completion Date

March 8, 2023

Study Completion Date

March 8, 2023

Conditions
Stress
Interventions
DEVICE

Light therapy A via the Re-Timer®

Subjects will conduct light treatment in the mornings at home.

DEVICE

Light therapy B via the Re-Timer®

Subjects will conduct light treatment in the mornings at home.

DEVICE

Light therapy C via the Re-Timer®

Subjects will conduct light treatment in the mornings at home.

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Michigan

OTHER

NCT04117347 - Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity | Biotech Hunter | Biotech Hunter